| Ident. | Authors (with country if any) | Title |
|---|
| 000607 |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Supaksorn Thika [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Cristiano Noto [Brésil] ; Rada Ivanova [Bulgarie] ; Michael Maes [Thaïlande] | Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway. |
| 000A31 |
Chutima Roomruangwong [Thaïlande] ; Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; George Anderson [Royaume-Uni] ; André F. Carvalho [Brésil] ; Sebastien Duleu [France] ; Michel Geffard [France] ; Michael Maes [Thaïlande] | IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway. |
| 000A33 |
Chutima Roomruangwong [Thaïlande] ; Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; George Anderson [Royaume-Uni] ; André F. Carvalho [Brésil] ; Sebastien Duleu [France] ; Michel Geffard [France] ; Michael Maes [Thaïlande] | IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome. |
| 000E65 |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; Heidi Ormstad [Norvège] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid. |
| 000E66 |
Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation. |
| 001024 |
Buranee Kanchanatawan [Thaïlande] ; Solaphat Hemrungrojn [Thaïlande] ; Supaksorn Thika [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; Kiat Ruxrungtham [Thaïlande] ; André F. Carvalho [Brésil] ; Michel Geffard [France] ; George Anderson [Royaume-Uni] ; Michael Maes [Thaïlande] | Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia. |
| 001234 |
Chutima Roomruangwong [Thaïlande] ; Decio Sabbatini Barbosa [Brésil] ; Andressa Keiko Matsumoto [Brésil] ; André De Souza Nogueira [Brésil] ; Buranee Kanchanatawan [Thaïlande] ; Sunee Sirivichayakul [Thaïlande] ; André F. Carvalho [Brésil] ; Sebastien Duleu [France] ; Michel Geffard [France] ; Estefania Gastaldello Moreira [Brésil] ; Michael Maes [Australie] | Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby. |
| 002292 |
Chutima Roomruangwong [Thaïlande] ; Buranee Kanchanatawan [Thaïlande] ; André F. Carvalho [Brésil] ; Sunee Sirivichayakul [Thaïlande] ; Sebastien Duleu [France] ; Michel Geffard [France] ; Michael Maes [Thaïlande] | Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway. |
| 004572 |
Michele W. Tang [États-Unis] ; Soo-Yon Rhee [États-Unis] ; Silvia Bertagnolio [Suisse] ; Nathan Ford [Suisse] ; Susan Holmes [États-Unis] ; Kim C. Sigaloff [Pays-Bas] ; Raph L. Hamers [Pays-Bas] ; Tobias F. Rinke De Wit [Pays-Bas] ; Herve J. Fleury [France] ; Phyllis J. Kanki [États-Unis] ; Kiat Ruxrungtham [Thaïlande] ; Claudia A. Hawkins [États-Unis] ; Carole L. Wallis [Afrique du Sud] ; Wendy Stevens [Afrique du Sud] ; Gert U. Van Zyl [Afrique du Sud] ; Weerawat Manosuthi [Thaïlande] ; Mina C. Hosseinipour [Malawi] ; Nicole Ngo-Giang-Huong [Thaïlande] ; Laurent Belec [France] ; Martine Peeters [France] ; Avelin Aghokeng [France, Cameroun] ; Torsak Bunupuradah ; Sherri Burda [États-Unis] ; Patricia Cane [Royaume-Uni] ; Giulia Cappelli [Cameroun, Italie] ; Charlotte Charpentier [France] ; Anoumou Y. Dagnra [Togo] ; Alaka K. Deshpande [Inde] ; Ziad El-Katib [Canada, Suède] ; Susan H. Eshleman [États-Unis] ; Joseph Fokam [Cameroun] ; Jean-Chrysostome Gody [République centrafricaine] ; David Katzenstein [États-Unis] ; Donato D. Koyalta [Tchad] ; Johnstone J. Kumwenda [Malawi] ; Marc Lallemant [États-Unis, Thaïlande] ; Lutgarde Lynen [Belgique] ; Vincent C. Marconi [Géorgie (pays)] ; Nicolas A. Margot [États-Unis] ; Sandrine Moussa [République centrafricaine] ; Thumbi Ndung'U [Afrique du Sud] ; Phillipe N. Nyambi [États-Unis] ; Catherine Orrell [Afrique du Sud] ; Jonathan M. Schapiro [Israël] ; Rob Schuurman [Pays-Bas] ; Sunee Sirivichayakul [Thaïlande] ; Davey Smith [États-Unis] ; Maria Zolfo [Belgique] ; Michael R. Jordan [États-Unis] ; Robert W. Shafer [États-Unis] | Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out Stavudine |
